J Tollemar1, O Ringdén. Show Affiliations » 1. Department of Transplantation Surgery, Huddinge Hospital, Karolinska Institutet, Stockholm, Sweden.
Abstract
Entities: Chemical Disease
Mesh: See more » Amphotericin B/adverse effectsAmphotericin B/chemistryAmphotericin B/economicsAmphotericin B/therapeutic useAntifungal Agents/adverse effectsAntifungal Agents/chemistryAntifungal Agents/economicsAntifungal Agents/therapeutic useChemistry, PharmaceuticalClinical Trials as TopicCommunicable Diseases/drug therapyCost-Benefit AnalysisDrug Carriers/standardsDrug Delivery Systems/standardsDrug ToleranceHumansLipidsLiposomesTreatment Outcome
Substances: See more » Antifungal AgentsDrug CarriersLipidsLiposomesAmphotericin B
Year: 1995 PMID: 8573294 DOI: 10.2165/00002018-199513040-00001
Source DB: PubMed Journal: Drug Saf ISSN: 0114-5916 Impact factor: 5.606